Committed to
the highest standards
of clinical research

Browse >

Clinical Research Information For Sponsors

Founded in 1987, the Chicago Institute of Neurosurgery and Neuroresearch (CINN) has emerged as one of the nation's leading institutions for the diagnosis, treatment and rehabilitation of patients with nervous system conditions. CINN treats more patients with brain tumors and spine disorders than any other institution in Illinois. Currently, we have 7 centers servicing more than 20,000 patients annually, and our Network represents one of the largest and busiest neuroscience practices in the country.

CINN comprises one of the nation's largest, most proficient groups of neurosurgeons, whose members represent every subspecialty in the field. Also included in the CINN network are physicians in related fields such as neurology, physiatry and internal medicine. More patients choose CINN for the surgical care than any other institution in the Chicago area.

Since 1995, CINN has been committed to recruiting, managing and executing clinical research protocols to the hishest standards for the pharmaceutical and medical device industries. Our objective is to constantly strive for flawless execution of protocols. We have a highly dedicated and experienced clinical research staff and can accommodate Phase I through Phase IV class protocols. We are also experienced in the design and management of comprehensive, longitudinal quality of life studies relating to clinical outcomes.

CINN has the clinical expertise and patient population to conduct
research in:

  1. Alzheimer's Disease
  2. Pain Management
  3. Vascular Disorders including aneurysms and AVMs
  4. Brain tumors—primary and metastatic
  5. Parkinson's Disease
  6. Carpal Tunnel Syndrome
  7. Peripheral Neuropathy
  8. Devices
  9. Seizure Disorders
  10. Epilepsy
  11. Headache
  12. Migraine Headaches
  13. Movement Disorders
  14. Stroke
  15. Musculoskelatal Diseases
  16. Spine Disorders including Degenerative Disc Disease Osteoarthritis Trauma Congenital Malformations Tumor and Vascular Abnormalities


CINN has conducted studies with the following companies:

  1. Archus Orthopedics, Inc.
  2. Link Spine Group, Inc.
  3. Bertlex Laboratories, Inc.
  4. Medtronic, Inc.
  5. Boston Scientific Corporation
  6. NeoPharm, Inc.
  7. Ceregene, Inc.
  8. NeuroPace, Inc.
  9. Codman & Shurtleff, Inc.
  10. Northstar Neuroscience, Inc.
  11. Confluent Surgical, Inc.
  12. Novartis Pharmaceuticals
  13. Cortek, Inc.
  14. Ortho Biotech Inc.
  15. DePuy AcroMed Corporation
  16. Osteotech Inc.
  17. Fidia Pharmaceutical
  18. Seacoast Therapeutics, Inc.
  19. Genzyme Biomatrix, Inc.
  20. Sofamor Danek Inc.
  21. Gliatech Inc.
  22. Stereotaxis, Inc.
  23. Guilford Pharmaceuticals
  24. Sulzer-Spine Tech Inc.
  25. Integra LifeSciences Corporation
  26. Synthes Spine
  27. Interpore Cross International
  28. U.S. Surgical Dynamics, Inc.
  29. Johnson & Johnson Professionals


Work for contract research organizations has included:

  1. Berger-Boyer & Associates
  2. Boston Biostatistics, Inc.
  3. INC Research
  4. J. Tyson & Associates, Inc.
  5. Medical Device Consultants, Inc.
  6. PAREXEL International Corp.
  7. PPD Development
  8. Quintiles, Inc.
  9. Statprobe, Inc.
  10. Sulzer-Spine Tech Inc.



FOR FURTHER INFORMATION

A list of current trials. For more information, please contact Vice President of Endovascular Services and Research. She can also be reached by mail at CINN, 4501 North Winchester Avenue, 3rd Floor, Chicago, Illinois, 60640 or by phone at 773/250-0500.